Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 28  •  04:00PM ET
10.10
Dollar change
-0.28
Percentage change
-2.70
%
Index
RUT
P/E
-
EPS (ttm)
-0.93
Insider Own
4.65%
Shs Outstand
49.85M
Perf Week
-5.43%
Market Cap
506.99M
Forward P/E
-
EPS next Y
-0.66
Insider Trans
-2.99%
Shs Float
47.54M
Perf Month
29.16%
Enterprise Value
368.77M
PEG
-
EPS next Q
-0.22
Inst Own
93.81%
Perf Quarter
-1.27%
Income
-46.65M
P/S
2.88
EPS this Y
-153.76%
Inst Trans
-1.45%
Perf Half Y
-6.13%
Sales
176.18M
P/B
1.09
EPS next Y
12.76%
ROA
-4.94%
Perf YTD
5.21%
Book/sh
9.23
P/C
1.23
EPS next 5Y
-
ROE
-8.02%
52W High
11.45 -11.79%
Perf Year
77.19%
Cash/sh
8.19
P/FCF
-
EPS past 3/5Y
-0.23% 13.68%
ROIC
-8.58%
52W Low
5.31 90.21%
Perf 3Y
-52.00%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
-9.45% 17.49%
Gross Margin
39.99%
Volatility
4.43% 4.34%
Perf 5Y
-81.34%
Dividend TTM
-
EV/Sales
2.09
EPS Y/Y TTM
62.52%
Oper. Margin
-25.09%
ATR (14)
0.43
Perf 10Y
317.36%
Dividend Ex-Date
-
Quick Ratio
2.07
Sales Y/Y TTM
-22.86%
Profit Margin
-26.48%
RSI (14)
58.18
Dividend Gr. 3/5Y
- -
Current Ratio
2.17
EPS Q/Q
49.12%
SMA20
3.13%
Beta
1.76
Payout
-
Debt/Eq
0.46
Sales Q/Q
-23.65%
SMA50
14.08%
Rel Volume
1.00
Prev Close
10.38
Employees
738
LT Debt/Eq
0.08
SMA200
10.86%
Avg Volume
418.16K
Price
10.10
IPO
Jan 31, 2005
Option/Short
Yes / Yes
Trades
Volume
418,058
Change
-2.70%
Date Action Analyst Rating Change Price Target Change
Aug-06-25Upgrade Leerink Partners Market Perform → Outperform $16
Aug-06-25Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Jul-22-25Resumed Stephens Overweight $13
Mar-24-25Upgrade UBS Neutral → Buy $10
Dec-19-24Initiated Guggenheim Buy $11
Aug-07-24Downgrade Jefferies Buy → Hold $20 → $8
Jul-31-24Upgrade B. Riley Securities Neutral → Buy $19 → $15
May-03-24Downgrade B. Riley Securities Buy → Neutral $22 → $19
Apr-04-24Resumed Jefferies Buy $17 → $21
Mar-13-24Reiterated Needham Buy $19 → $18
Apr-20-26 04:05PM
Mar-04-26 08:30AM
12:00AM
Mar-03-26 07:02PM
05:25PM
04:05PM Loading…
04:05PM
Feb-18-26 08:10AM
Feb-17-26 08:00AM
Feb-11-26 08:30AM
08:16AM
Nov-05-25 12:09AM
Nov-04-25 05:50PM
04:05PM
Nov-03-25 08:01AM
Oct-30-25 08:30AM
08:00AM Loading…
Oct-21-25 08:00AM
Oct-17-25 04:09AM
Oct-07-25 08:30AM
Oct-01-25 08:30AM
Aug-06-25 03:32AM
Aug-05-25 06:35PM
04:19PM
Aug-04-25 05:55PM
10:02AM
Jul-31-25 05:25PM
10:00AM
Jul-29-25 10:00AM
Jul-25-25 09:55AM
Jul-22-25 08:00AM
Jul-08-25 08:00AM
07:45AM Loading…
07:45AM
Jul-04-25 12:00PM
Jun-27-25 12:00PM
Jun-12-25 08:00AM
May-28-25 09:55AM
May-12-25 09:55AM
May-08-25 03:34AM
May-07-25 07:15PM
07:15PM
05:20PM
04:05PM
May-06-25 09:35AM
Apr-30-25 10:01AM
Apr-24-25 08:30AM
Apr-10-25 10:39AM
Apr-04-25 06:03AM
Mar-31-25 03:11PM
09:06AM
08:09AM
Mar-26-25 09:15AM
Mar-18-25 07:59PM
Mar-13-25 07:28AM
Mar-12-25 08:30AM
Mar-05-25 02:10AM
Mar-04-25 05:35PM
04:10PM
Mar-03-25 07:18AM
Feb-18-25 08:30AM
Jan-21-25 08:30AM
Jan-14-25 08:30AM
Jan-06-25 08:30AM
Nov-12-24 08:30AM
Nov-08-24 04:03PM
Nov-07-24 05:55PM
04:05PM
Nov-06-24 07:37AM
Oct-31-24 10:01AM
Oct-29-24 08:30AM
Oct-22-24 08:30AM
Oct-21-24 08:30AM
Oct-15-24 08:30AM
Oct-07-24 08:30AM
Sep-25-24 08:30AM
Sep-09-24 05:28AM
Aug-19-24 03:27AM
Aug-06-24 07:00PM
04:15PM
04:05PM
Jul-23-24 08:30AM
Jul-12-24 02:46AM
Jul-09-24 09:35AM
Jun-20-24 08:30AM
May-17-24 02:33AM
May-08-24 02:54PM
04:03AM
May-07-24 09:56PM
06:18PM
04:08PM
May-03-24 10:12AM
06:41AM
Apr-30-24 08:30AM
Apr-25-24 10:02AM
Mar-13-24 09:16AM
Mar-12-24 05:52PM
05:30PM
04:05PM
Feb-27-24 08:30AM
Feb-15-24 10:00AM
Feb-13-24 09:55AM
Nov-27-23 08:30AM
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHELTON JERRELLPresident, CEOApr 21 '26Option Exercise1.87104,007194,4931,230,614Apr 23 08:00 PM
SHELTON JERRELLPresident, CEOApr 06 '26Option Exercise1.8750,00093,5001,126,607Apr 08 06:32 PM
STEFANOVICH ROBERTChief Financial OfficerMar 23 '26Sale8.181,0948,949279,277Mar 25 08:01 PM
SHELTON JERRELLPresident, CEOMar 23 '26Option Exercise1.8725,00046,7501,076,607Mar 25 08:00 PM
SHELTON JERRELLPresident, CEOMar 23 '26Sale8.182,89423,6731,051,607Mar 25 08:00 PM
Sawicki Mark WChief Scientific OfficerMar 23 '26Sale8.181,34110,969102,356Mar 25 08:00 PM
ZECCHINI EDWARD JSee RemarksMar 16 '26Sale8.002,01416,112109,719Mar 17 08:01 PM
SHELTON JERRELLPresident, CEOMar 16 '26Sale8.007,91863,3441,054,501Mar 17 08:00 PM
Sawicki Mark WChief Scientific OfficerMar 16 '26Sale8.003,23525,880103,697Mar 17 08:00 PM
STEFANOVICH ROBERTChief Financial OfficerMar 12 '26Option Exercise1.8787,188163,042294,401Mar 16 09:35 PM
STEFANOVICH ROBERTChief Financial OfficerMar 12 '26Sale7.7638,700300,386255,701Mar 16 09:35 PM
STEFANOVICH ROBERTChief Financial OfficerMar 16 '26Sale8.002,74321,944280,371Mar 16 09:35 PM
ROBERT S. STEFANOVICHOfficerMar 12 '26Proposed Sale7.7638,700300,386Mar 12 04:17 PM
Mandalam RamkumarDirectorDec 10 '25Sale9.9911,570115,54080,758Dec 12 05:30 PM
RAMKUMAR MANDALAMDirectorDec 10 '25Proposed Sale9.9911,570115,540Dec 10 04:10 PM
Hariri Robert JDirectorSep 11 '25Option Exercise2.6650,000133,00076,275Sep 12 05:30 PM
Hariri Robert JDirectorSep 11 '25Sale9.7125,000242,73851,275Sep 12 05:30 PM
ROBERT HARIRIDirectorSep 11 '25Proposed Sale9.7125,000242,738Sep 11 04:29 PM
Hariri Robert JDirectorAug 22 '25Sale8.605,00043,00026,275Aug 29 06:46 PM
STEFANOVICH ROBERTChief Financial OfficerAug 19 '25Option Exercise3.0726,16480,323216,513Aug 21 05:00 PM
STEFANOVICH ROBERTChief Financial OfficerAug 19 '25Sale8.679,30080,618207,213Aug 21 05:00 PM
ROBERT S. STEFANOVICHOfficerAug 19 '25Proposed Sale8.679,30080,618Aug 19 04:40 PM
SHELTON JERRELLPresident, CEOAug 13 '25Option Exercise5.0025,000125,0001,062,419Aug 15 05:00 PM
SHELTON JERRELLPresident, CEOJul 31 '25Option Exercise5.0025,000125,0001,037,419Aug 04 06:00 PM
SHELTON JERRELLPresident, CEOJul 24 '25Option Exercise5.0025,000125,0001,012,419Jul 28 05:04 PM
Mandalam RamkumarDirectorJul 22 '25Option Exercise3.0760,000184,200133,056Jul 24 05:00 PM
Mandalam RamkumarDirectorJul 22 '25Sale7.2440,728294,89992,328Jul 24 05:00 PM
SHELTON JERRELLPresident, CEOJul 18 '25Option Exercise5.0025,000125,000987,419Jul 22 04:52 PM
RAMKUMAR MANDALAMDirectorJul 22 '25Proposed Sale6.7140,728273,285Jul 22 04:10 PM
SHELTON JERRELLPresident, CEOJul 08 '25Option Exercise5.0025,000125,000962,419Jul 10 05:00 PM
SHELTON JERRELLPresident, CEOJun 25 '25Option Exercise5.0025,000125,000937,419Jun 26 08:00 PM
SHELTON JERRELLPresident, CEOJun 24 '25Option Exercise5.0016,34481,720928,763Jun 26 08:00 PM
SHELTON JERRELLPresident, CEOJun 24 '25Sale7.0616,344115,366912,419Jun 26 08:00 PM
Mandalam RamkumarDirectorJun 24 '25Option Exercise3.0720,00061,40086,377Jun 26 08:00 PM
Mandalam RamkumarDirectorJun 24 '25Sale7.0113,32193,44773,056Jun 26 08:00 PM
RAMKUMAR MANDALAMDirectorJun 24 '25Proposed Sale6.5613,32187,386Jun 24 04:09 PM
SHELTON JERRELLPresident, CEOJun 17 '25Option Exercise5.00201,3041,006,5201,063,723Jun 20 08:15 PM
SHELTON JERRELLPresident, CEOJun 18 '25Option Exercise5.00119,281596,4051,031,700Jun 20 08:15 PM
SHELTON JERRELLPresident, CEOJun 20 '25Option Exercise5.0069,135345,675981,554Jun 20 08:15 PM
SHELTON JERRELLPresident, CEOJun 17 '25Sale6.81151,3041,029,715912,419Jun 20 08:15 PM
SHELTON JERRELLPresident, CEOJun 18 '25Sale6.81119,281812,542912,419Jun 20 08:15 PM
SHELTON JERRELLPresident, CEOJun 20 '25Sale6.4769,135447,525912,419Jun 20 08:15 PM
JERRELL W SHELTONDirectorJun 17 '25Proposed Sale6.93356,0642,467,524Jun 17 04:14 PM
Mandalam RamkumarDirectorJun 11 '25Sale7.068,19357,81668,896Jun 13 07:00 PM
Mandalam RamkumarDirectorJun 12 '25Sale7.011,89513,28667,001Jun 13 07:00 PM
Mandalam RamkumarDirectorJun 13 '25Sale6.806244,24666,377Jun 13 07:00 PM
RAMKUMAR MANDALAMDirectorJun 13 '25Proposed Sale6.806244,246Jun 13 04:12 PM
RAMKUMAR MANDALAMDirectorJun 12 '25Proposed Sale7.011,89513,286Jun 12 04:18 PM
RAMKUMAR MANDALAMDirectorJun 11 '25Proposed Sale7.018,19357,463Jun 11 04:21 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 10 '25Option Exercise3.0775,000230,250141,911Jun 10 07:28 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 10 '25Sale6.8451,500352,51890,411Jun 10 07:28 PM
Mandalam RamkumarDirectorJun 09 '25Sale7.065,62239,67377,089Jun 10 07:25 PM
EDWARD ZECCHINIOfficerJun 10 '25Proposed Sale6.8451,500352,512Jun 10 04:29 PM
RAMKUMAR MANDALAMDirectorJun 09 '25Proposed Sale7.065,62239,673Jun 09 05:33 PM
SHELTON JERRELLPresident, CEOJun 04 '25Option Exercise5.0050,000250,000862,419Jun 06 02:21 PM
Hariri Robert JDirectorMay 28 '25Sale6.1012,50076,2508,061May 30 07:00 PM